Acrysof IQ Vivity Toric Extended Vision Intraocular Lens Implantation for Presbyopia

N/A

Waitlist Available

Led By Georges Durr, MD, FRCSC

Research Sponsored by Centre hospitalier de l'Université de Montréal (CHUM)

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 months

Awards & highlights

No Placebo-Only Group

Summary

This trial is studying a special lens used in cataract surgery that helps people see better at different distances and corrects astigmatism. These lenses have become the preferred choice for surgeons to correct vision issues during cataract surgery. The lens is designed to stay stable in the eye, which is important for clear vision. The goal is to reduce the need for glasses and improve quality of life for patients with significant astigmatism.

Eligible Conditions

Presbyopia
Pseudoaphakia
Cataract
Corneal Astigmatism

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Binocular uncorrected visual acuities for distance (6 meters), intermediate (66 centimeters), and near (40 centimeters)

Secondary study objectives

Mean absolute intraocular lens rotation (subjective)

Mean refractive spherical equivalent

Monocular best corrected distance visual acuities (at 6 meters), and distance corrected intermediate (66 centimeters) and near (40 centimeters) visual acuities

+4 more

Other study objectives

Mean absolute intraocular lens rotation (objective)

Mean absolute prediction error